Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (13702)	8/20/1998 2:00:00 PM
From: VLAD	Respond to of 23519

FRESH INFORMATION: Letter to Dr. Friedman sent TODAY! citizen.org

To: VLAD who wrote (13702)	8/20/1998 2:58:00 PM
From: AlienTech	Respond to of 23519

I like this.. >> Pfizer's profitability has not been adversely affected by current laws protecting patients from dangerous pharmaceuticals and faulty medical devices. << According to Lobbying Disclosure reports, in the first half of 1996, Pfizer spent at least $1,070,000 lobbying Congress to weaken federal laws that protect patients from dangerous products, prevent illegal price-fixing of prescription drugs and preserve clean air and clean water. >> Pfizer has spent hundreds of thousands of dollars supporting congressional candidates who decide on matters of direct concern to the company. << In the 1995-96 election cycle, Pfizer's corporate PAC made $423,381 in campaign contributions -$51,000 was contributed to Senate Republicans -$18,000 was contributed to Senate Democrats An additional $133,620 in campaign contributions was made by employees of Pfizer in the 1995-96 elections, including: - a $20,000 soft money contribution to the RNC National State Election Committee - $26,000 from officers of the company